Serrated pathway to colorectal carcinogenesis: A molecular perspective

Current Colorectal Cancer Reports

Volumn 7, Issue 1, 2011, Pages 50-57

  Goel, Ajay ^b   Balaguer, Francesc ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

Aberrant crypt foci; BRAF mutation; Colorectal cancer; CpG island methylator phenotype or CIMP; DNA methylation; Hyperplastic polyps; KRAS mutations; MGMT methylation; Microsatellite instability; MLH1 methylation; Serrated adenocarcinoma; Serrated polyps; Sessile serrated adenoma

Indexed keywords

B RAF KINASE; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; PROTEIN P53;

ADENOMA; CANCER DIAGNOSIS; CARCINOGENESIS; COLORECTAL CANCER; DNA METHYLATION; GENE MUTATION; HISTOLOGY; HUMAN; HYPERPLASIA; MICROSATELLITE INSTABILITY; POLYP; REVIEW;

EID: 79952699230     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-010-0082-x     Document Type: Review

References (50)

1. Goldman H, Ming S, Hickock DF: Nature and significance of hyperplastic polyps of the human colon. Arch Pathol 1970; 89 (4):349-354.
2. Urbanski SJ, Kossakowska AE, Marcon N, Bruce WR: Mixed hyperplastic adenomatous polyps-an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp. Am J Surg Pathol 1984; 8(7):551-556. (Pubitemid 14083982)
3. Longacre TA, Fenoglio-Preiser CM: Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 1990; 14(6):524-537. (Pubitemid 20172523)
4. Tateyama H, Li W, Takahashi E, et al.: Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorectum: the saw-toothed structure may be related to inhibition of apoptosis. Am J Surg Pathol 2002; 26(2):249-256. (Pubitemid 34127506)
5. Warner AS, Glick ME, Fogt F: Multiple large hyperplastic polyps of the colon coincident with adenocarcinoma. Am J Gastroenterol 1994; 89(1):123-125. (Pubitemid 24020067)
6. Renaut AJ, Douglas PR, Newstead GL: Hyperplastic polyposis of the colon and rectum. Colorectal Dis 2002; 4(3):213-215. (Pubitemid 34567883)
7. Hawkins NJ, Ward RL: Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001; 93(17):1307-1313. (Pubitemid 32910571)
8. Goldstein NS: Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am J Clin Pathol 2006; 125(1):146-153.
9. Torlakovic E, Skovlund E, Snover DC, et al.: Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003; 27(1):65-81. (Pubitemid 36014900)
10. Noffsinger AE, Hart J: Serrated adenoma: a distinct form of nonpolypoid colorectal neoplasia? Gastrointest Endosc Clin N Am 2010; 20(3):543-563.
11. Cheng L, Lai MD: Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol 2003; 9(12):2642-2649. (Pubitemid 38054431)
12. Schreiner MA, Weiss DG, Lieberman DA: Proximal and Large Hyperplastic and Nondysplastic Serrated Polyps Detected by Colonoscopy Are Associated With Neoplasia. Gastroenterology 2010; 139:1497-1502.
13. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP: Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 2005; 124(3):380-391. (Pubitemid 41232924)
14. Jass JR, Baker K, Zlobec I, et al.: Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology 2006; 49(2):121-131.
15. Iino H, Jass JR, Simms LA, et al.: DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol 1999; 52(1):5-9.
16. Jass JR, Whitehall VL, Young J, Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology 2002; 123(3):862-876. (Pubitemid 34977092)
17. Young J, Simms LA, Biden KG, et al.: Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 2001; 159(6):2107-2116. (Pubitemid 33104265)
18. Jass JR, Young J, Leggett BA: Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology 2000; 37(4):295-301.
19. Oh K, Redston M, Odze RD: Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplasticadenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol 2005; 36(1):101-111. (Pubitemid 40215639)
20. Kambara T, Simms LA, Whitehall VL, et al.: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004; 53(8):1137-1144. (Pubitemid 38961968)
21. Whitehall VL, Walsh MD, Young J, et al.: Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001; 61(3):827-830. (Pubitemid 32174386)
22. Wynter CV, Walsh MD, Higuchi T, et al.: Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut 2004; 53(4):573-580. (Pubitemid 38372984)
23. Jass JR, Biden KG, Cummings MC, et al.: Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999; 52(6):455-460. (Pubitemid 29281765)
24. Jass JR: HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences. Fam Cancer 2004; 3(2):93-100.
25. Rosenberg DW, Yang S, Pleau DC, et al.: Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res 2007; 67(8):3551-3554. (Pubitemid 46762136)
26. O'Brien MJ, Yang S, Mack C, et al.: Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006; 30(12):1491-1501. (Pubitemid 44808785)
27. Kim KM, Lee EJ, Kim YH, et al.: KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol 2010; 34(5):667-675.
28. Carr NJ, Mahajan H, Tan KL, et al.: Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 2009; 62 (6):516-518. This article analyzes the prevalence of serrated polyps in an unselected population, and correlates the morphological diagnoses with BRAF mutations.
29. O'Brien MJ, Yang S, Clebanoff JL, et al.: Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol 2004; 28(4):423-434. (Pubitemid 38436515)
30. Kim YH, Kakar S, Cun L, et al.: Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Int J Cancer 2008; 123(11):2587-2593.
31. Yang S, Farraye FA, Mack C, et al.: BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 2004; 28(11):1452-1459. (Pubitemid 39425511)
32. Spring KJ, Zhao ZZ, Karamatic R, et al.: High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006; 131(5):1400-1407. (Pubitemid 44708940)
33. Lee EJ, Choi C, Park CK, et al.: Tracing origin of serrated adenomas with BRAF and KRAS mutations. Virchows Arch 2005; 447(3):597-602. (Pubitemid 41291632)
34. Vaughn CP, Wilson AR, Samowitz WS: Quantitative evaluation of CpG island methylation in hyperplastic polyps. Mod Pathol 2010; 23(1):151-156.
35. Chan TL, Zhao W, Leung SY, Yuen ST: BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 2003; 63(16):4878-4881. (Pubitemid 37022620)
36. Domingo E, Niessen RC, Oliveira C, et al.: BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene 2005; 24 (24):3995-3998. (Pubitemid 40896411)
37. Suzuki H, Igarashi S, Nojima M, et al.: IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis 2010; 31(3):342-349.
38. Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349 (21):2042-2054. (Pubitemid 37448928)
39. Toyota M, Ahuja N, Ohe-Toyota M, et al.: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999; 96(15):8681-8686. (Pubitemid 29354851)
40. Esteller M, Catasus L, Matias-Guiu X, et al.: hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol 1999; 155(5):1767-1772.
41. Weisenberger DJ, Siegmund KD, Campan M, et al.: CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38(7):787-793. (Pubitemid 43980599)
42. Leggett B, Whitehall V: Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010; 138 (6):2088-2100. This recent review article summarizes the current knowledge about the serrated pathway in colorectal cancer with its clinical implications.
43. Beach R, Chan AO, Wu TT, et al.: BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 2005; 166 (4):1069-1075. (Pubitemid 40524431)
44. Minoo P, Baker K, Goswami R, et al.: Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006; 55(10):1467-1474.
45. Frazier ML, Xi L, Zong J, et al.: Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res 2003; 63(16):4805-4808. (Pubitemid 37022610)
46. Jass JR: Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2005; 2(8):398-405.
47. Rashid A, Houlihan PS, Booker S, et al.: Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000; 119(2):323-332. (Pubitemid 30621982)
48. Yashiro M, Laghi L, Saito K, et al.: Serrated adenomas have a pattern of genetic alterations that distinguishes them from other colorectal polyps. Cancer Epidemiol Biomarkers Prev 2005; 14 (9):2253-2256. (Pubitemid 41603275)
49. Fu X, Li J, Li K, et al.: Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas. Histopathology 2009; 55 (5):554-563.
50. Loh K, Chia JA, Greco S, et al.: Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosomes Cancer 2008; 47(6):449-460. (Pubitemid 351657180)